Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Soluble epoxide hydrolase inhibitor, TPPU, increases regulatory T cells pathway in an arthritis model.

Authors: Trindade-da-Silva, Carlos A; Clemente-Napimoga, Juliana T; Abdalla, Henrique B; Rosa, Sergio Marcolino; Ueira-Vieira, Carlos; Morisseau, Christophe; Verri Jr, Waldiceu A; Montalli, Victor Angelo Martins; Hammock, Bruce D; Napimoga, Marcelo H

Published In FASEB J, (2020 07)

Abstract: Epoxyeicosatrienoic acids (EET) and related epoxy fatty acids (EpFA) are endogenous anti-inflammatory compounds, which are converted by the soluble epoxide hydrolase (sEH) to dihydroxylethersatrienoic acids (DHETs) with lessened biological effects. Inhibition of sEH is used as a strategy to increase EET levels leading to lower inflammation. Rheumatoid arthritis is a chronic autoimmune disease that leads to destruction of joint tissues. This pathogenesis involves a complex interplay between the immune system, and environmental factors. Here, we investigate the effects of inhibiting sEH with 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU) on a collagen-induced arthritis model. The treatment with TPPU ameliorates hyperalgesia, edema, and decreases the expression of important pro-inflammatory cytokines of Th1 and Th17 profiles, while increasing Treg cells. Considering the challenges to control RA, this study provides robust data supporting that inhibition of the sEH is a promising target to treat arthritis.

PubMed ID: 32400048 Exiting the NIEHS site

MeSH Terms: Animals; Arthritis, Experimental/chemically induced; Arthritis, Experimental/drug therapy; Arthritis, Experimental/immunology*; Arthritis, Experimental/pathology; Collagen/toxicity; Epoxide Hydrolases/antagonists & inhibitors*; Inflammation/etiology; Inflammation/pathology; Inflammation/prevention & control*; Male; Mice; Mice, Inbred DBA; Phenylurea Compounds/pharmacology*; Piperidines/pharmacology*; T-Lymphocytes, Regulatory/drug effects; T-Lymphocytes, Regulatory/immunology*

to Top